Japanese company profile · 7575

Japan Lifeline Co., Ltd.

English company name recorded in Japan's EDINET filer data.

Original Japanese company name: 日本ライフライン株式会社

Name follows the English name recorded in EDINET filer data. English company name source

FY2025 · fiscal year ended March 2026Latest filing date: 2026-06-19

What does this company do?

What does this company do?

In its FY2025 public filing, Japan Lifeline Co., Ltd. reports Manufacture and sale of medical devices. The page shows business-level revenue and profit where the source disclosures support comparison.

Japan Lifeline Co., Ltd.'s largest reported business by revenue in FY2025 was Manufacture and sale of medical devices.

The business with the highest reported segment profit in FY2025 was Manufacture and sale of medical devices.

FY2025 · fiscal year ended March 2026 · View original filing ↗ The source document may be in Japanese.

Reported company-wide figures

Company revenue
¥59.19B ↗
FY2025 · fiscal year ended March 2026
Operating profit
¥12.61B ↗
FY2025 · fiscal year ended March 2026
Comparable margin
21.3% ↗
FY2025 · fiscal year ended March 2026

JGAAP · Consolidated company-wide

Company profile

Company profile

Identity

Securities code
7575
EDINET code
E02881
Corporate number
2010701020987
Listing status
Listed
Industry (EDINET filer classification)
Wholesale trade

Location and fiscal year

Headquarters
東京都品川区 · As filed in Japanese
Fiscal year end
3month
Latest fiscal year
FY2025
Accounting standard
JGAAP
P16 data snapshot
2026-11-07

Company size

Employees (consolidated)
1,304 people (FY2025)
Employees (non-consolidated)
1,085 people (FY2025)
Capital stock
JPY 2.1 billion (FY2025)

Official information

Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab

Business structure

How does it make money?

Revenue leader and profit leader

Manufacture and sale of medical devices

FY2025 · fiscal year ended March 2026 · Business Sales Operating profit
BusinessSalesShare of company salesOperating profitMargin
Manufacture and sale of medical devices¥59.19B ↗—¥12.61B ↗21.3%

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.

Company revenue

Company-wide trend

No comparable company-wide annual series is available in the current source snapshot.

What has changed?

What has changed?

Not disclosed or not safely comparable in the available filings.

What is growing?

What is growing?

No comparable reported revenue growth is available.

What has changed?

What has changed?

A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.

Source

Company profile

These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.

  • Growth—
    No comparable data
  • Profitability99
    Peer-position scoreFY2025
  • Business concentration—
    No comparable data
  • Business change—
    No comparable data
  • Cash generation96
    Peer-position scoreFY2025
  • Growth persistence—
    No comparable data

Next

Ask about this company

Source

Public filing

FY2025 · fiscal year ended March 2026

The source document may be in Japanese.

Filing ID: S100YEH7

View original filing ↗

根拠となる資料